TrialScientific reports2024

Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial).

Nuttapat Tungtrongchitr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.